229 related articles for article (PubMed ID: 36276069)
1. Quantitative parameters of enhanced dual-energy computed tomography for differentiating lung cancers from benign lesions in solid pulmonary nodules.
He C; Liu J; Li Y; Lin L; Qing H; Guo L; Hu S; Zhou P
Front Oncol; 2022; 12():1027985. PubMed ID: 36276069
[TBL] [Abstract][Full Text] [Related]
2. Differentiating pulmonary metastasis from benign lung nodules in thyroid cancer patients using dual-energy CT parameters.
Ha T; Kim W; Cha J; Lee YH; Seo HS; Park SY; Kim NH; Hwang SH; Yong HS; Oh YW; Kang EY; Kim C
Eur Radiol; 2022 Mar; 32(3):1902-1911. PubMed ID: 34564746
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Quantitative Dual-Energy Computed Tomography Parameters for Differentiation of Parotid Gland Tumors.
Wang Y; Hu H; Ban X; Jiang Y; Su Y; Yang L; Shi G; Yang L; Han R; Duan X
Acad Radiol; 2024 May; 31(5):2027-2038. PubMed ID: 37730491
[TBL] [Abstract][Full Text] [Related]
4. [Comparative imaging study of mediastinal lymph node from pre-surgery dual energy CT
Zhu Q; Ren C; Zhang Y; Li MJ; Wang XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):730-737. PubMed ID: 32773811
[TBL] [Abstract][Full Text] [Related]
5. A Single Enhanced Dual-Energy CT Scan May Distinguish Lung Squamous Cell Carcinoma From Adenocarcinoma During the Venous phase.
Zhang Z; Zou H; Yuan A; Jiang F; Zhao B; Liu Y; Chen J; Zuo M; Gong L
Acad Radiol; 2020 May; 27(5):624-629. PubMed ID: 31447258
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of malignant from benign orbital tumours using dual-energy CT.
Luo S; Sha Y; Wu J; Lin N; Pan Y; Zhang F; Huang W
Clin Radiol; 2022 Apr; 77(4):307-313. PubMed ID: 35094818
[TBL] [Abstract][Full Text] [Related]
7. Dual-energy CT quantitative parameters for the differentiation of benign from malignant lesions and the prediction of histopathological and molecular subtypes in breast cancer.
Wang X; Liu D; Zeng X; Jiang S; Li L; Yu T; Zhang J
Quant Imaging Med Surg; 2021 May; 11(5):1946-1957. PubMed ID: 33936977
[TBL] [Abstract][Full Text] [Related]
8. Differentiating malignant from benign gastric mucosal lesions with quantitative analysis in dual energy spectral computed tomography: Initial experience.
Meng X; Ni C; Shen Y; Hu X; Chen X; Li Z; Hu D
Medicine (Baltimore); 2017 Jan; 96(2):e5878. PubMed ID: 28079827
[TBL] [Abstract][Full Text] [Related]
9. Value of dual-layer spectral detector computed tomography in the diagnosis of benign/malignant solid solitary pulmonary nodules and establishment of a prediction model.
Xie X; Liu K; Luo K; Xu Y; Zhang L; Wang M; Shen W; Zhou Z
Front Oncol; 2023; 13():1147479. PubMed ID: 37213284
[TBL] [Abstract][Full Text] [Related]
10. Invasive Pulmonary Adenocarcinomas Versus Preinvasive Lesions Appearing as Pure Ground-Glass Nodules: Differentiation Using Enhanced Dual-Source Dual-Energy CT.
Yang Y; Li K; Sun D; Yu J; Cai Z; Cao Y; Wu J
AJR Am J Roentgenol; 2019 Sep; 213(3):W114-W122. PubMed ID: 31082273
[No Abstract] [Full Text] [Related]
11. Can Spectral CT Imaging Improve the Differentiation between Malignant and Benign Solitary Pulmonary Nodules?
Zhang Y; Cheng J; Hua X; Yu M; Xu C; Zhang F; Xu J; Wu H
PLoS One; 2016; 11(2):e0147537. PubMed ID: 26840459
[TBL] [Abstract][Full Text] [Related]
12. Quantitative parameters derived from dual-energy computed tomography for the preoperative prediction of early recurrence in patients with esophageal squamous cell carcinoma.
Liu Y; Cheng F; Wang L; Du L; Shen H; Wang X; Zeng Z; Liu D; Tao J; Wu J; Zhang J
Eur Radiol; 2023 Nov; 33(11):7419-7428. PubMed ID: 37314470
[TBL] [Abstract][Full Text] [Related]
13. Effect of Hashimoto's thyroiditis on the dual-energy CT quantitative parameters and performance in diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer.
Geng D; Zhou Y; Shang T; Su GY; Lin SS; Si Y; Wu FY; Xu XQ
Cancer Imaging; 2024 Jan; 24(1):10. PubMed ID: 38238870
[TBL] [Abstract][Full Text] [Related]
14. Dual-energy computed tomography could reliably differentiate metastatic from non-metastatic lymph nodes of less than 0.5 cm in patients with papillary thyroid carcinoma.
Zou Y; Zheng M; Qi Z; Guo Y; Ji X; Huang L; Gong Y; Lu X; Ma G; Xia S
Quant Imaging Med Surg; 2021 Apr; 11(4):1354-1367. PubMed ID: 33816174
[TBL] [Abstract][Full Text] [Related]
15. Differentiation Between Solitary Pulmonary Inflammatory Lesions and Solitary Cancer Using Gemstone Spectral Imaging.
Zhu LH; Wang FN; Wang YW; Cheng QH; Zhou JJ
J Comput Assist Tomogr; 2022 Mar-Apr 01; 46(2):300-307. PubMed ID: 35081600
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Effectiveness of Dual Source Dual Energy Computed Tomography for Benign and Malignant Thyroid Nodules.
Zhu T; Xie K; Wang C; Wang L; Liu W; Zhang F
Evid Based Complement Alternat Med; 2022; 2022():2257304. PubMed ID: 36034942
[TBL] [Abstract][Full Text] [Related]
17. Dual-source dual-energy computed tomography-derived quantitative parameters combined with machine learning for the differential diagnosis of benign and malignant thyroid nodules.
Jiang L; Liu D; Long L; Chen J; Lan X; Zhang J
Quant Imaging Med Surg; 2022 Feb; 12(2):967-978. PubMed ID: 35111598
[TBL] [Abstract][Full Text] [Related]
18. Mono+ algorithm assessment of the diagnostic value of dual-energy CT for high-risk factors for colorectal cancer: a preliminary study.
Chen JF; Yang J; Chen WJ; Wei X; Yu XL; Huang DD; Deng H; Luo YD; Liu XJ
Quant Imaging Med Surg; 2024 Jan; 14(1):432-446. PubMed ID: 38223051
[TBL] [Abstract][Full Text] [Related]
19. Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer.
Wang X; Liu D; Zeng X; Jiang S; Li L; Yu T; Zhang J
Cancer Imaging; 2021 Jan; 21(1):4. PubMed ID: 33413654
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment dual-energy CT for predicting early response to induction chemotherapy and survival in nasopharyngeal carcinoma.
Zhan Y; Wang Y; Wang P; Wang Y; Ni X; Wang J; Tang Z
Eur Radiol; 2023 Dec; 33(12):9052-9062. PubMed ID: 37405505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
